Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?

Mar 22 2017

• By Lauren Nardella and Ryan Nelson

Related Content

Risks Of Missing Reauthorization Deadline Highlighted At User-Fee Hearing

Mar 21 2017

ICMAD Looks To Sway Legislators To Sessions Cosmetics Bill

Oct 26 2016

FDA Looking At Over $20 Million Annually In Proposed Cosmetics Fees

Apr 30 2015

Pending FDA User-Fee Legislation May Be ‘Big Shot’ For Cosmetics Reg Reform

Feb 28 2017

PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises

Jan 23 2017

Cosmetics Stakeholders Race To Hitch Reform Provisions To FDA User-Fee Bills

Mar 03 2017

FDA Commish Nominee Could Be Mixed Blessing For Cosmetics Industry

Mar 15 2017

Additional Topics

United States FDA Policy Cosmetics Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window